BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh S, Huda P, Fletcher N, Campbell D, Thurecht KJ, Walsh B. Clinical development of an anti-GPC-1 antibody for the treatment of cancer. Expert Opinion on Biological Therapy. [DOI: 10.1080/14712598.2022.2033204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Busato D, Mossenta M, Dal Bo M, Macor P, Toffoli G. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. IJMS 2022;23:10279. [DOI: 10.3390/ijms231810279] [Reference Citation Analysis]